Neoadjuvant therapy with Disitamab vedotin in treating muscle-invasive bladder cancer: A case report

PURPOSE: Platinum-based regimens are regarded as the preferred alternative for neoadjuvant chemotherapy for muscle-invasive bladder cancer (MIBC) patients. However, some patients cannot tolerate platinum-based regimens. We report an MIBC case with severe renal insufficiency treated by neoadjuvant th...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Haijun, Zhang, Yucong, Chen, Zhi, Zeng, Xing, Hu, Zhiquan, Yang, Chunguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130214/
https://www.ncbi.nlm.nih.gov/pubmed/37123934
http://dx.doi.org/10.1016/j.heliyon.2023.e15157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130214/
https://www.ncbi.nlm.nih.gov/pubmed/37123934
http://dx.doi.org/10.1016/j.heliyon.2023.e15157

Ejemplares similares